BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2018
View Archived Issues
FDA approves IND application for clinical study of RK-01
Read More
FDA approves Rituxan for moderate to severe pemphigus vulgaris
Read More
NOSO-502: a new antibacterial drug candidate active against carbapenem-resistant Enterobacteriaceae
Read More
Bayer closes its acquisition of Monsanto
Read More
Modest data for PI3K inhibitor taselisib in breast cancer
Read More
Dana-Farber Cancer Institute patents new PROTAC compounds for cancer
Read More
Bristol-Myers Squibb divulges integrin alphaV antagonists
Read More
Prolia approved in Europe for patients with glucocorticoid-induced osteoporosis
Read More
Merck & Co. identifies Nav1.7 channel blockers
Read More
Amgen presents new apelin receptor agonists
Read More
Rapalimus gel launched in Japan for the treatment of angiofibromas in tuberous sclerosis
Read More
FDA approves Venclexta plus rituximab for previously treated CLL and SLL
Read More
Idorsia initiates phase II registration program for nemorexant in insomnia
Read More
EBX-205, a new oral broad-spectrum antibiotic active against bioterrorism pathogens
Read More
Evgen offers interim update from phase II STEM trial of SFX-01 in advanced breast cancer
Read More
Tagrisso approved in E.U. for first-line EGFR-mutated NSCLC
Read More
Responses to M-7824 in phase I study lead to phase II trial in HPV-associated cancers
Read More
MaxCyte and NIH enter CRADA for sickle cell disease
Read More
First-in-human study evaluates AZD-4205 with osimertinib in advanced NSCLC
Read More
Saniona to study Tesomet in phase IIa trial for hypothalamic obesity
Read More
NeuroVia initiates phase I/II trial of NV-1205 in childhood cerebral adrenoleukodystrophy
Read More
Pfizer initiates phase II study of PF-06730512 in primary focal segmental glomerulosclerosis
Read More
Taiho studies TAS-0728 in solid tumors with HER2 or HER3 abnormalities
Read More
SHP2, a potential therapeutic target in KRAS-mutant tumors
Read More
FDA clears IND for phase I trial of CK-0801 for bone marrow failure syndromes
Read More
